NMPA Approval

Piperacillin Sodium and Tazobactam Sodium for Injection(4:1)

Approval Number

国药准字H20143181

Company珠海联邦制药股份有限公司中山分公司

Registration Date

March 13, 2020

Drug Information

Generic Name

注射用哌拉西林钠他唑巴坦钠(4:1)

Dosage Form

注射剂

Strength

0.625g(C23H27N5O7S 0.5g与C10H12N4O5S 0.125g)

Drug Type

化学药品

Registration Date

March 13, 2020

Company Information

Applicant Company

Company Name珠海联邦制药股份有限公司中山分公司

Manufacturing Company

Company Name珠海联邦制药股份有限公司中山分公司

Company Address

广东省中山市坦洲镇嘉联路12号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

注射用哌拉西林钠他唑巴坦钠(4:1) - NMPA 批准文号 | MedPath